The US FDA Has Approved The First Treatment, Remdesivir, For Covid-19. Remdesivir Is Sold Under The Brand Name Veklury, Which Has Been Used Under Emergency Use Authorization Since May 2020. Remdesivir Is “Indicated For Adults And Pediatric Patients (12 Yrs And Older And Weighing At least 40 kg) Treatment Requiring Hospitalization.”
Gilead’s remdesivir first to win US approval to treat COVID-19 | US & Canada News | Al JazeeraRemdesivir was previously authorised for emergency use in the treatment of hospitalised COVID-19 patients.